genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Cancer testing
Industry News
European Commission Orders Illumina to Divest of Grail
News
Illumina Vows Appeal of $479M Fine for Acquiring Grail before EC Approval
Close to the Edge
Carl Icahn States His Case for Change at Illumina on “Close to the Edge”
Cancer
AACR News: GRAIL Validates Methylation-Based Cancer Detection Test
GEN Edge
StockWatch: Illumina Shares Steady as Icahn Escalates Proxy Fight
Insights
Exclusive: RBC Analyst Weighs in on Icahn’s Proxy Battle for Illumina
Cancer
Strata Oncology Validates Clinical Utility of Solid Tumor Predictive Biomarker
Cancer
CRISPR Tech Lights Up Cancer Biomarker miRNAs in Plasma Exosomes
Cancer
At JPM, Illumina Announces African-American Sequencing Collaboration
Cancer
Test May Predict Recurrence and Response to Immunotherapy in Melanoma Patients
1
2
3
...
5
Page 1 of 5
Scroll Up
Scroll Up
